Form 8-K - Current report:
SEC Accession No. 0001193125-13-150572
Filing Date
2013-04-11
Accepted
2013-04-11 12:29:01
Documents
8
Period of Report
2013-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d520239d8k.htm 8-K 27874
2 EX-1.1 d520239dex11.htm EX-1.1 31676
3 EX-3.1 d520239dex31.htm EX-3.1 90081
4 EX-4.1 d520239dex41.htm EX-4.1 76985
5 EX-4.2 d520239dex42.htm EX-4.2 8363
6 EX-10.1 d520239dex101.htm EX-10.1 189721
7 EX-10.2 d520239dex102.htm EX-10.2 119813
8 GRAPHIC g520239ex1_1pg1.jpg GRAPHIC 13896
  Complete submission text file 0001193125-13-150572.txt   565143
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 13755487
SIC: 2836 Biological Products, (No Diagnostic Substances)